News

Show
news from

Slingshot Therapeutics strengthens its team through the appointment of Ed Savory as Head of Chemistry

Kesmalea Therapeutics Appoints Industry Veteran Tim Clackson to Board of Directors

Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation

Purespring Therapeutics appoints Haseeb Ahmad as Chief Executive Officer

OMass Therapeutics appoints Birgitte Volck as Non-Executive Director

Yellowstone Biosciences appoints Dr. Ita O’Kelly, previously Executive Director Product Management at Immunocore, as its Chief Operating Officer and a member of its Leadership Team

Load more

Search